短程大剂量山莨菪碱及地塞米松救治外科危重病人186例

CLINICAL RESEARCH ON THE SHORT RANGE TREATMENT OF 186 CRITICAL SURGICAL PATIENTS BY LARGE DOSE ANISODAMINUM AND DEXAMETHASONE

总结了采用大剂量山莨菪碱及地塞米松救治危重外科病人１８６例。ＡＰＣＡＣＨＥ－Ⅱ积分为９～３４（１７．０６±６．３９）分，死亡１９例，病死率为１０．２％，取得了较好的效果。临床观察到该方法对危重病人有遏止危重状态进展，促进症状缓解，改善微循环及良好的降温、抗毒、抗炎、抗休克作用，对重要脏器无损伤作用。

critical surgical patients were treated by a large dose anisodaminum and dexamethasone,their age was 10～93 years,averaged 43 43. Among them,125 were male and 61 female.APACHE Ⅱ scored 9～34,averaged 17 06±6 39.19 died, the mortality was 10 2%.The result was satisfactory.Clinical observation showed that this method could prevent the critical condition from deteriorating, relieve the suffering, and promote microcirculation. It was also effcetive in anti shock, anti inflammation, anti toxic treatment with no harmful effect on the vital organs.